Genmab · 20 hours ago
Associate Director, Forecasting and Business Analytics
Princeton
Full-time
Hybrid
Lead/Staff, Director/Executive
$164K/yr - $246K/yr
8+ years expGenmab is an international biotechnology company dedicated to improving patient lives through innovative antibody therapeutics. The Associate Director, Business Analytics & Forecasting will develop and manage forecasting and business analytics, oversee data acquisitions, and support business planning to enhance the Business Insights function at Genmab.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Influence commercial, R&D, and total company decisions with analysis and forecasts
Develop methodical and accurate analytical tools, forecast models and overall process plan to support leadership in creating alignment across global stakeholders and commercial organizations at the country level
Provide expertise in forecasting for new product commercialization and in-line opportunities
Provide analytical support and identify, in collaboration with key stakeholders, business issues and growth opportunities ahead of routine performance reviews (Board Meetings, Quarterly Analyst Calls, Annual Performance / Forecast Reviews)
Own and manage the tracking and monitoring platforms (dashboards, reports, etc.) after deployment
Ensure cross functional alignment and data integrity across all stakeholders (global /local) and identify possible solutions /areas of improvements for countries in data reporting and quality
Coordinate with external vendors to manage data and key related initiatives
Develop and implement optimal tools for:
Patient and market share forecasts
Forecasting patient flows
Align forecasting and analytics process to business reviews
Technical aspects of forecast and model development
KPI Launch / Post Launch Dashboards
Outputs to clearly reflect source of business, competitive landscape
Ensure data integrity across therapeutic areas by setting market definitions and reviewing global and country data purchases
Qualification
Required
Bachelor's Degree with 5+ years, or Master's Degree (Statistics/Biostatistics, Mathematics, MBA) with 4+ years of pharma/biotech experience
8+ years of Analytics OR Forecasting experience (US or Global)
Oncology, hematology, OR Rare Disease experience is required
Demonstrable evidence of multi-cultural sensitivity
Ability to drive complex enterprise wide change initiatives with executive level stakeholders
Experience successfully leading global projects with tight timelines
High resilience and agility; creative in problem solving
Demonstrate a performance mindset with strong personal accountability and ability to collaborate across geographic and functional boundaries
Excellent oral and written communication skills
Strategic and analytical mindset
Benefits
401(k) Plan: 100% match on the first 6% of contributions
Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
1001-5000 employees
H1B Sponsorship
Genmab has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (10)
2023 (6)
2022 (3)
2021 (3)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Leadership Team
Anthony Pagano
Chief Financial Officer
Anthony Mancini
EVP & Chief Operating Officer
Recent News
Labiotech UG
2026-02-07
2026-01-20
2026-01-19
Company data provided by crunchbase